#5-14E. Bridging the Regulatory Gap: Modernizing Dietary Supplement Oversight (AIM, 2026)

Are you fully aware of the dietary supplements your patients are taking alongside their prescribed medications? Currently in the United States, dietary supplements are regulated as a subcategory of food, bypassing the FDA's premarket review and approval. This inadequate regulatory framework has allowed adulterated and mislabeled products to repeatedly enter the market, posing a significant public health threat. In response, this position paper from the American College of Physicians proposes urgent policy changes, including bolstering the FDA’s pre- and postmarket regulatory authority, standardizing supplement terminology, and improving data sharing. The most critical clinical takeaway is the call to integrate comprehensive dietary supplement knowledge databases directly into electronic health records to alert clinicians about potential interactions with prescribed medications. However, when critically appraising this article, it is important to note that it is a policy position paper and literature review, rather than a primary study presenting new clinical trial data. For physicians, this paper is highly relevant as it underscores the necessity of systematically documenting supplement use in daily practice—similar to prescription medication workflows—to mitigate adverse drug-supplement interactions and ultimately ensure patient safety.

Citation: Cline K., Beachy M. W., Carr P. W. Modernizing the Regulatory Framework for Dietary Supplements: A Position Paper From the American College of Physicians. Annals of Internal Medicine. 2026. DOI: 10.7326/ANNALS-26-01119

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.